Clinical Trial

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-03-22; most recent amendment 2025-08-12.
Status change: Recruiting → Active, Not Recruiting 2025-08-12
Status change: Not Yet Recruiting → Recruiting 2023-10-02
Trial Details
NCT Number NCT05796453
Lead Sponsor Alcon Research
Conditions Aphakia, Astigmatism, Presbyopia
Enrollment 470 participants
Start Date 2023-09-19
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2025-08-14